Fortis Capital Advisors LLC Cuts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Fortis Capital Advisors LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 10.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 389 shares of the healthcare conglomerate’s stock after selling 45 shares during the quarter. Fortis Capital Advisors LLC’s holdings in UnitedHealth Group were worth $197,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also bought and sold shares of the company. NewSquare Capital LLC purchased a new stake in UnitedHealth Group during the 4th quarter valued at $25,000. Hurley Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $28,000. AlphaMark Advisors LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at about $30,000. Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $30,000. Finally, Promus Capital LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $32,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 0.8 %

Shares of NYSE:UNH opened at $599.10 on Friday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock’s fifty day moving average price is $512.87 and its 200-day moving average price is $542.03. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market cap of $548.00 billion, a P/E ratio of 38.65, a PEG ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the previous year, the company earned $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.40%. UnitedHealth Group’s payout ratio is 54.19%.

Insider Activity

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of research analyst reports. Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Mizuho raised their price objective on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday. Truist Financial increased their target price on UnitedHealth Group from $610.00 to $660.00 and gave the stock a “buy” rating in a research report on Friday. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty-one investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $632.85.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.